6monon MSN
According to the letter, the violations were related to Globus Medical’s (GMED) Class II Excelsius GPS (EGPS) surgical robot ...
Analyst Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report) and keeping the price target at $91.00. Ryan Zimmerman’s rating is based on a combination of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback